Back to selection
Semester | fall semester 2024 |
Course frequency | Every fall sem. |
Lecturers |
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch)
Alex Odermatt (alex.odermatt@unibas.ch) Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, Assessor) |
Content | Introduction to disease and medication Examples of large pharma projects Start-up vs big pharma Pharmaceutical innovation Treatment developments in neuroinflammatory diseases Preclinical development Clinical drug development Role of drug agencies in drug development New developments in oncology / in the treatment of hypercholesterolemia Multiple approaches to tackle COVID-19 New developments in virology |
Weblink | Department of Pharmaceutical Sciences |
Admission requirements | Compulsory attendance 100%. This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
Course application | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
Language of instruction | English |
Use of digital media | No specific media used |
Interval | Weekday | Time | Room |
---|---|---|---|
wöchentlich | Monday | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Date | Time | Room |
---|---|---|
Monday 16.09.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 23.09.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 30.09.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 07.10.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 14.10.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 21.10.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 04.11.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 11.11.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 18.11.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 25.11.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 02.12.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 09.12.2024 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Modules |
Doctorate Pharmaceutical Sciences: Recommendations (PhD subject: Pharmaceutical Sciences) Doctorate Toxicology: Recommendations (PhD subject: Toxicology) Electives Master Science in Pharmacy: Recommendations (Master's Studies: Science in Pharmacy) Module Specialisation: Medical Nanosciences (Master's Studies: Nanosciences) Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences) |
Assessment format | continuous assessment |
Assessment details | Regular attendance and presentation. More details will be communicated during the first lecture. |
Assessment registration/deregistration | Reg.: course registration, dereg: cancel course registration |
Repeat examination | no repeat examination |
Scale | Pass / Fail |
Repeated registration | as often as necessary |
Responsible faculty | Faculty of Science, studiendekanat-philnat@unibas.ch |
Offered by | Departement Pharmazeutische Wissenschaften |